368 related articles for article (PubMed ID: 12095984)
1. Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A.
Clarke SJ; McStay GP; Halestrap AP
J Biol Chem; 2002 Sep; 277(38):34793-9. PubMed ID: 12095984
[TBL] [Abstract][Full Text] [Related]
2. The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition.
Leung AW; Varanyuwatana P; Halestrap AP
J Biol Chem; 2008 Sep; 283(39):26312-23. PubMed ID: 18667415
[TBL] [Abstract][Full Text] [Related]
3. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection.
Hausenloy D; Wynne A; Duchen M; Yellon D
Circulation; 2004 Apr; 109(14):1714-7. PubMed ID: 15066952
[TBL] [Abstract][Full Text] [Related]
4. Cyclophilin D as a drug target.
Waldmeier PC; Zimmermann K; Qian T; Tintelnot-Blomley M; Lemasters JJ
Curr Med Chem; 2003 Aug; 10(16):1485-506. PubMed ID: 12871122
[TBL] [Abstract][Full Text] [Related]
5. Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore.
Lim SY; Davidson SM; Hausenloy DJ; Yellon DM
Cardiovasc Res; 2007 Aug; 75(3):530-5. PubMed ID: 17512507
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury.
Hausenloy DJ; Duchen MR; Yellon DM
Cardiovasc Res; 2003 Dec; 60(3):617-25. PubMed ID: 14659807
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial permeability transition pore as a target for cardioprotection in the human heart.
Shanmuganathan S; Hausenloy DJ; Duchen MR; Yellon DM
Am J Physiol Heart Circ Physiol; 2005 Jul; 289(1):H237-42. PubMed ID: 15961375
[TBL] [Abstract][Full Text] [Related]
8. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart.
Javadov SA; Clarke S; Das M; Griffiths EJ; Lim KH; Halestrap AP
J Physiol; 2003 Jun; 549(Pt 2):513-24. PubMed ID: 12692185
[TBL] [Abstract][Full Text] [Related]
9. A Phenyl-Pyrrolidine Derivative Reveals a Dual Inhibition Mechanism of Myocardial Mitochondrial Permeability Transition Pore, Which Is Limited by Its Myocardial Distribution.
Panel M; Ahmed-Belkacem A; Ruiz I; Guichou JF; Pawlotsky JM; Ghaleh B; Morin D
J Pharmacol Exp Ther; 2021 Mar; 376(3):348-357. PubMed ID: 33303698
[TBL] [Abstract][Full Text] [Related]
10. Divergent Effects of Cyclophilin-D Inhibition on the Female Rat Heart: Acute Versus Chronic Post-Myocardial Infarction.
Parodi-Rullán RM; Soto-Prado J; Vega-Lugo J; Chapa-Dubocq X; Díaz-Cordero SI; Javadov S
Cell Physiol Biochem; 2018; 50(1):288-303. PubMed ID: 30282073
[TBL] [Abstract][Full Text] [Related]
11. Curcumin-induced melanoma cell death is associated with mitochondrial permeability transition pore (mPTP) opening.
Qiu Y; Yu T; Wang W; Pan K; Shi D; Sun H
Biochem Biophys Res Commun; 2014 May; 448(1):15-21. PubMed ID: 24735534
[TBL] [Abstract][Full Text] [Related]
12. The role of the mitochondrial permeability transition pore in heart disease.
Halestrap AP; Pasdois P
Biochim Biophys Acta; 2009 Nov; 1787(11):1402-15. PubMed ID: 19168026
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury.
Halestrap AP; Connern CP; Griffiths EJ; Kerr PM
Mol Cell Biochem; 1997 Sep; 174(1-2):167-72. PubMed ID: 9309682
[TBL] [Abstract][Full Text] [Related]
14. The permeability transition pore complex: another view.
Halestrap AP; McStay GP; Clarke SJ
Biochimie; 2002; 84(2-3):153-66. PubMed ID: 12022946
[TBL] [Abstract][Full Text] [Related]
15. Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Petrosillo G; Colantuono G; Moro N; Ruggiero FM; Tiravanti E; Di Venosa N; Fiore T; Paradies G
Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1487-93. PubMed ID: 19684190
[TBL] [Abstract][Full Text] [Related]
16. Pre-clinical evaluation of cinobufotalin as a potential anti-lung cancer agent.
Kai S; Lu JH; Hui PP; Zhao H
Biochem Biophys Res Commun; 2014 Sep; 452(3):768-74. PubMed ID: 25201730
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial targeted cyclophilin D protects cells from cell death by peptidyl prolyl isomerization.
Lin DT; Lechleiter JD
J Biol Chem; 2002 Aug; 277(34):31134-41. PubMed ID: 12077116
[TBL] [Abstract][Full Text] [Related]
18. Cyclophilin sensitivity to sanglifehrin A can be correlated to the same specific tryptophan residue as cyclosporin A.
Pemberton TJ; Kay JE
FEBS Lett; 2003 Dec; 555(2):335-40. PubMed ID: 14644438
[TBL] [Abstract][Full Text] [Related]
19. Small-Molecule Inhibitors of Cyclophilins Block Opening of the Mitochondrial Permeability Transition Pore and Protect Mice From Hepatic Ischemia/Reperfusion Injury.
Panel M; Ruiz I; Brillet R; Lafdil F; Teixeira-Clerc F; Nguyen CT; Calderaro J; Gelin M; Allemand F; Guichou JF; Ghaleh B; Ahmed-Belkacem A; Morin D; Pawlotsky JM
Gastroenterology; 2019 Nov; 157(5):1368-1382. PubMed ID: 31336123
[TBL] [Abstract][Full Text] [Related]
20. Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart.
Halestrap AP; Kerr PM; Javadov S; Woodfield KY
Biochim Biophys Acta; 1998 Aug; 1366(1-2):79-94. PubMed ID: 9714750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
